Decreased nigral neuromelanin in Alzheimer's disease

By Reyes Marc G.   Faraldi Francesco   Rydman Robert   Ce Wang Charles  

Neurological Research, Vol. 25, Iss. 2, 2003-03 ,pp. : 179-182

Maney Publishing

Access to resources Recommend Favorite

Effect of entacapone on plasma homocysteine levels in Parkinson’s disease patients

By Nevrly Martin   Kanovsky Petr   Vranova Hana   Langova Katerina   Hlustik Petr  

Neurological Sciences, Vol. 31, Iss. 5, 2010-10 ,pp. : 565-569

Springer Publishing Company

Access to resources Recommend Favorite

Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 6, 2016-06 ,pp. : 654-662

Bentham Science Publishers

Access to resources Recommend Favorite

Fetal nigral transplantation as a therapy for Parkinson's disease

By Olanow C.W.   Kordower J.H.   Freeman T.B.  

Trends in Neurosciences, Vol. 19, Iss. 3, 1996-03 ,pp. : 102-109

Elsevier

Access to resources Recommend Favorite

The Weaver GIRK2 Mutation Leads to Decreased Levels of Serum Thyroid Hormone: Characterization of the Effect on Midbrain Dopaminergic Neuron Survival

By Blum M.   Weickert C.   Carrasco E.  

Experimental Neurology, Vol. 160, Iss. 2, 1999-12 ,pp. : 413-424

Elsevier

Access to resources Recommend Favorite